Ambu Q2 2024/25 Earnings Results and Financial Update

Loading viewer...

earnings

Format: PDF earnings

Ambu reports Q2 and H1 2024/25 results with 15.4% organic revenue growth and 15.2% EBIT margin expansion. The company achieved a strong start for its Ambu® SureLight™ Connect launch in pulmonology and continued positive momentum in urology. Management confirms current FY 2024/25 financial guidance.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Ambu

View all →

Ambu 2019 Full-Year Results Investor Presentation

investor_presentation

21 Pages

Ambu Analyst Meeting 2020 - aScope Endoscope Products

investor_presentation

Similar earningss from other companies

Browse all →

Caleres Q3 2016 Earnings Presentation

earnings

8 Pages

Caleres

Q3 2016 Financial Results Presentation

earnings